Ziarco Picks Up Pfizer Assets, Series A Round
This article was originally published in The Pink Sheet Daily
Executive Summary
A former Pfizer VP used four of the pharma’s programs to secure private financing from an unlikely investor and got the pharma to buy into the new start-up. Now, he hopes to develop next generation treatments for inflammatory and allergic diseases.